TerraPower Isotopes Announces New Philadelphia Manufacturing Facility

TerraPower Isotopes is building a flagship cGMP manufacturing facility in Philadelphia’s Bellwether District focused on producing actinium-225, a critical isotope used in cancer treatment research. Announced March 17, the facility is expected to increase production capacity twentyfold and improve supply availability for researchers and pharmaceutical developers. President Scott Claunch described the project as a major milestone for the company as demand grows for targeted radiopharmaceutical therapies and related medical research applications.